GB bobsleigh's Gulliver provisionally suspended
Great Britain bobsleigh athlete Arran Gulliver has been provisionally suspended for failing a doping test. The International ...
Former European bobsled champion Arran Gulliver fails a doping test
Former European bobsled champion Arran Gulliver has failed a doping test and been provisionally suspended, the International ...
British bobsleigher Arran Gulliver provisionally suspended after positive doping test
Britain's bobsledder Arran Gulliver has been provisionally suspended following a doping test failure, the International ...
Britain's Gulliver provisionally suspended after positive doping test
Britain's bobsledder Arran Gulliver has been provisionally suspended following a doping test failure, the International Testing Agency said on Monday.
Team GB bobsledder Arran Gulliver fails out-of-competition drugs test - putting 2026 Winter Olympics medal hopes in serious doubt
The 27-year-old, a key part of the four-man bobsleigh team that has been tipped for a medal at the Games in Italy, was ...
Weight-loss drug battle: Who are the latest players involved
The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...
pharmaphorum2d
Veru shares plunge despite positive data in obesity trial
Veru's enobosarm is designed to be used in combination with GLP-1 agonist-based obesity drugs – such as Novo Nordisk's blockbuster Wegovy (semaglutide) – to reduce the loss of lean muscle mass ...
Seeking Alpha17d
Weight-loss drug battle: Who are the latest players involved
Veru: Veru's (NASDAQ:VERU) lead asset, enobosarm, an androgen receptor modulator, is currently undergoing a Phase 2b trial to test its potential as a treatment to preserve muscle and improve fat ...